June 16, 2023
Astellas Pharma, Inc. v. Sandoz Inc.
Case Number:
23-2032
Court:
Nature of Suit:
835 Patent - (ANDA) (Fed. Qst.)
Companies
- Allergan PLC
- Astellas Pharma Inc.
- Aurobindo Pharma Ltd.
- Lupin Ltd.
- Prinston Pharmaceutical Inc.
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 18, 2024
Fed. Circ. Revives Astellas Patent Axed As Natural Law
The Federal Circuit on Wednesday vacated a lower court's invalidation of an Astellas Pharma overactive bladder medication patent for claiming only a natural law, saying the holding was improper because the generics makers accused of infringement never made that argument.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login